ProfileGDS4718 / 227948_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 95% 80% 96% 97% 88% 83% 94% 97% 96% 96% 98% 84% 83% 90% 95% 97% 89% 93% 94% 95% 96% 96% 97% 97% 88% 97% 90% 96% 92% 92% 88% 95% 96% 89% 87% 93% 94% 95% 79% 95% 84% 91% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.860197
GSM549102patient 115, normal, homogenized [OPG study]10.227595
GSM549104patient 119, normal, homogenized [OPG study]7.8790680
GSM549108patient 138, normal, homogenized [OPG study]10.634796
GSM549119patient 077, normal, homogenized [OPG study]10.994397
GSM549133patient 032, cancer, homogenized [OPG study]8.9897488
GSM549139patient 042, cancer, homogenized [OPG study]8.1937983
GSM549099patient 107, normal, homogenized [OPG study]9.9576194
GSM549109patient 139, normal, homogenized [OPG study]11.048797
GSM549110patient 046, normal, homogenized [OPG study]10.607196
GSM549114patient 063, normal, homogenized [OPG study]10.614896
GSM549122patient 082, normal, homogenized [OPG study]11.248598
GSM549134patient 033, cancer, homogenized [OPG study]8.3075384
GSM549136patient 036, cancer, homogenized [OPG study]8.285883
GSM549140patient 044, cancer, homogenized [OPG study]9.2923490
GSM549111patient 047, normal, homogenized [OPG study]10.343395
GSM549113patient 057, normal, homogenized [OPG study]10.991197
GSM549132patient 031, cancer, homogenized [OPG study]8.9478889
GSM549137patient 038, cancer, homogenized [OPG study]9.655893
GSM549142patient 047, cancer, homogenized [OPG study]9.5874794
GSM549100patient 110, normal, homogenized [OPG study]10.392395
GSM549107patient 135, normal, homogenized [OPG study]10.596296
GSM549115patient 068, normal, homogenized [OPG study]10.823296
GSM549116patient 072, normal, homogenized [OPG study]10.870997
GSM549120patient 078, normal, homogenized [OPG study]11.015297
GSM549131patient 030, cancer, homogenized [OPG study]8.9432288
GSM549118patient 074, normal, homogenized [OPG study]11.001997
GSM549129patient 027, cancer, homogenized [OPG study]9.1523690
GSM549123patient 088, normal, homogenized [OPG study]10.691596
GSM549124patient 006, cancer, homogenized [OPG study]9.3926292
GSM549126patient 015, cancer, homogenized [OPG study]9.519792
GSM549128patient 025, cancer, homogenized [OPG study]8.8499688
GSM549103patient 117, normal, homogenized [OPG study]10.145595
GSM549117patient 073, normal, homogenized [OPG study]10.681496
GSM549138patient 041, cancer, homogenized [OPG study]8.9810689
GSM549141patient 045, cancer, homogenized [OPG study]8.8500787
GSM549130patient 028, cancer, homogenized [OPG study]9.6471893
GSM549101patient 111, normal, homogenized [OPG study]9.8885994
GSM549105patient 128, normal, homogenized [OPG study]10.13395
GSM549106patient 134, normal, homogenized [OPG study]7.9022979
GSM549112patient 048, normal, homogenized [OPG study]10.399395
GSM549125patient 011, cancer, homogenized [OPG study]8.2340384
GSM549127patient 024, cancer, homogenized [OPG study]9.288891
GSM549135patient 035, cancer, homogenized [OPG study]8.870887